Gösterge TablosuPortföylerİzleme ListesiToplulukKeşfedinScreener
NOT FOR DISTRIBUTION
Loading...
  • Stoklar
  • /
  • Yazılım
1g önce güncellendi
IRI logo

Integrated Research LimitedASX:IRI Stok Raporu

Piyasa Değeri AU$51.5m
1g önce güncellendi
Hisse Fiyatı
n/a
1Y-31.3%
7D-5.0%
1D-1.7%
Portföy Değeri
​
Görünüm

Integrated Research Limited

ASX:IRI Stok Raporu

Piyasa değeri: AU$51.5m

  • Şirkete Genel Bakış
  • Değerleme
  • Gelecekteki Büyüme
  • Geçmiş Performans
  • Finansal Sağlık
  • Temettü
  • Yönetim
  • Sahiplik
  • Diğer Bilgiler
  • Hisse Senedi Topluluğu

Integrated Research (IRI) Hisse Özeti

Integrated Research Limited, iş açısından kritik bilgi işlem sistemlerinin performansını izlemeye yönelik yazılımların tasarımı, geliştirilmesi, uygulanması ve satışı ile uğraşmaktadır. Daha fazla detay

IRI temel anali̇z
Kar Tanesi Skoru
Değerleme2/6
Gelecekteki Büyüme4/6
Geçmiş Performans2/6
Finansal Sağlık6/6
Temettüler3/6

Ödüller

Adil değer tahminimizden 79.1% daha düşük bir oranda işlem görüyor

Kazançların yılda 49.71% oranında artması öngörülüyor

Risk Analizi

10.53% temettüsü kazançlar tarafından iyi karşılanmıyor

Anlamlı bir piyasa değeri yok ( A$51M )

Kar marjları (2.1%) geçen yılın (19.6%) altında


IRI Community Fair Values

Create Narrative

See what 10 others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
20.8% değerinin altında içsel indirim
AnalystConsensusTarget
•2mo ago

Cloud Adoption Will Boost IT Performance But Challenge Revenue Stability

265
0
9

Top Analyst Narratives

IRI logo
Integrated Research
20.8% değerinin altında içsel indirim

Cloud Adoption Will Boost IT Performance But Challenge Revenue Stability

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 25 Jun
Read Narrative
View all narratives

Integrated Research Limited Rakipler

Reckon

Symbol: ASX:RKN
Market cap: AU$51.0m

Credit Clear

Symbol: ASX:CCR
Market cap: AU$80.1m

SenSen Networks

Symbol: ASX:SNS
Market cap: AU$26.6m

JCurve Solutions

Symbol: ASX:JCS
Market cap: AU$12.0m

Fiyat Geçmişi ve Performans

Hisse fiyatlarındaki yükseliş, düşüş ve değişimlerin özeti Integrated Research
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıAU$0.28
52 Haftanın En Yüksek SeviyesiAU$0.43
52 Haftanın En Düşük SeviyesiAU$0.27
Beta1.53
1 Aylık Değişim-5.00%
3 Aylık Değişim0%
1 Yıllık Değişim-31.33%
3 Yıllık Değişim-20.83%
5 Yıllık Değişim-84.47%
Halka arzdan bu yana değişim-80.07%

Son Haberler & Güncellemeler

Recent updates

Analiz Makalesi • Jul 14

Why Integrated Research Limited (ASX:IRI) Could Be Worth Watching

Integrated Research Limited ( ASX:IRI ), might not be a large cap stock, but it saw a decent share price growth of 11...
User avatar
Anlatı Güncellemesi • Jun 25

IRI: New AI Observability Offerings Will Support Future Upside

Analysts have kept their A$0.36 price target for Integrated Research unchanged, citing only very small adjustments to inputs such as the discount rate, long run revenue growth, profit margin and future P/E assumptions. What’s in the News for Integrated Research Integrated Research announced Iris for Card Payments, an AI powered assistant built on the Prognosis observability platform that uses natural language prompts to provide real time card payments insights.
User avatar
Anlatı Güncellemesi • Jun 08

IRI: Product Vision Day And Steady Assumptions Will Support Future Upside

Analysts have reiterated an A$0.36 fair value for Integrated Research, with only minor tweaks to the discount rate, revenue growth, profit margin and forward P/E assumptions. This signals that their updated modelling leaves the overall valuation view broadly intact.
User avatar
Anlatı Güncellemesi • May 24

IRI: Product Vision Day And Stable Assumptions Will Support Long Term Upside

Analysts have maintained their A$0.36 price target for Integrated Research, noting that only minor adjustments to the discount rate, revenue growth, profit margin and forward P/E assumptions were made and that these did not materially change their valuation view. What's in the News Integrated Research scheduled an Analyst and Investor Day focused on outlining its product vision and innovation strategy (Key Developments).
User avatar
Anlatı Güncellemesi • Apr 20

IRI: Product Vision Day And Stable Assumptions Will Support Long Term Upside

Analysts have kept their fair value estimate for Integrated Research steady at A$0.36. Only small technical adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions informed the updated price target stance.
User avatar
Anlatı Güncellemesi • Apr 05

IRI: Product Vision Day And Stable Assumptions Will Support Long Term Upside

Analysts have kept the A$ price target for Integrated Research broadly unchanged, with only a marginal adjustment that reflects slightly updated assumptions for discount rate, revenue growth, profit margins and future P/E multiples. What's in the News Integrated Research has scheduled an Analyst/Investor Day focused on outlining its product vision for the business.
User avatar
Anlatı Güncellemesi • Mar 22

IRI: Steady Assumptions And Product Vision Update Will Support Long Term Upside

Analysts have kept the price target for Integrated Research steady at A$0.36, citing only minor tweaks to inputs such as the discount rate, revenue growth, profit margin and future P/E assumptions, rather than any major shift in the outlook. What's in the News Integrated Research has scheduled an Analyst and Investor Day, giving you a chance to hear directly from management about the business and its direction (company event filing).
User avatar
Anlatı Güncellemesi • Mar 08

IRI: Revised Margins And P/E Assumptions Will Support Long Term Upside

Analysts have trimmed their fair value estimate for Integrated Research from A$0.40 to A$0.36. This reflects updated assumptions that pair a slightly higher discount rate and future P/E multiple with more cautious profit margin expectations and revised revenue growth forecasts.
User avatar
Anlatı Güncellemesi • Feb 21

IRI: New AI Observability Capabilities Will Support Long Term Upside Potential

Analysts have slightly trimmed their price target for Integrated Research to A$0.40, reflecting small updates to discount rate assumptions and expected future P/E, while keeping fair value and key operating assumptions broadly unchanged. What's in the News Integrated Research launched Iris, a conversational AI intelligence layer for multi vendor unified communications and collaboration observability, built on the company’s Prognosis platform.
User avatar
Anlatı Güncellemesi • Feb 06

IRI: New AI Observability Platform Will Support Long Term Upside

Analysts have adjusted their price target for Integrated Research to account for a slightly higher discount rate and a modestly revised future P/E expectation, resulting in a small change in estimated valuation levels. What's in the News Integrated Research launched Iris, a conversational AI intelligence layer for multi vendor unified communications and collaboration observability, built on the company’s Prognosis platform and designed to turn complex monitoring data into plain language answers for IT teams and business users.
Analiz Makalesi • Feb 06

Is Now The Time To Look At Buying Integrated Research Limited (ASX:IRI)?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it saw a decent share price growth...
User avatar
Anlatı Güncellemesi • Jan 23

IRI: New AI Observability Layer Will Support Long Term Upside

Analysts have made only a marginal adjustment to their price target for Integrated Research, reflecting slightly updated views on discount rates, long term revenue growth, profit margins, and the future P/E multiple, while keeping their fair value estimate broadly in line with prior assumptions. What's in the News Integrated Research launched Iris, a conversational AI intelligence layer embedded in its Prognosis platform, designed to turn complex observability data from unified communications and collaboration environments into plain language insights for IT and business users.
User avatar
Anlatı Güncellemesi • Jan 08

IRI: Cloud Observability Services And AI Features Will Support Long Term Upside

Analysts have kept their fair value estimate for Integrated Research broadly steady, making only minor tweaks to inputs such as discount rate, revenue growth, profit margin and future P/E. These changes feed into a small adjustment in the overall price target and reflect a largely unchanged view of the company’s medium term risk and earnings profile.
User avatar
Anlatı Güncellemesi • Dec 17

IRI: Cloud Observability Expansion Is Expected To Support Long Term Upside

Analysts have modestly raised their integrated research price target, citing incremental adjustments to discount rate assumptions and forward valuation multiples that support a fair value estimate now framed around improved long term earnings visibility. What's in the News Integrated Research launched Iris, a conversational AI intelligence layer embedded in its Prognosis observability platform.
User avatar
Anlatı Güncellemesi • Dec 02

IRI: New Cloud Platform Launch Is Expected To Drive Future Upside

Analysts have slightly reduced their price target for Integrated Research, reflecting minor adjustments in discount rate and future price-to-earnings assumptions. Key financial projections remain essentially unchanged.
User avatar
Anlatı Güncellemesi • Nov 18

IRI: Revenue Setbacks Will Be Outweighed By New Platform Launch

Analysts have revised their price target for Integrated Research downward from $0.55 to $0.40. They cite lowered revenue growth projections and compressed profit margins as the primary factors behind the adjustment.
Analiz Makalesi • Nov 14

Integrated Research Limited's (ASX:IRI) Prospects Need A Boost To Lift Shares

Integrated Research Limited's ( ASX:IRI ) price-to-earnings (or "P/E") ratio of 4.1x might make it look like a strong...
Analiz Makalesi • Aug 30

Integrated Research (ASX:IRI) Is Paying Out A Dividend Of A$0.02

The board of Integrated Research Limited ( ASX:IRI ) has announced that it will pay a dividend on the 21st of October...
User avatar
Anlatı Güncellemesi • Aug 27

Revenue May Stabilize While Profit Margins Decline In The Coming Years

Despite a notable increase in consensus revenue growth forecasts, a sharp decline in the future P/E multiple has driven the consensus analyst price target for Integrated Research down from A$0.70 to A$0.55. What's in the News Integrated Research previewed enhanced Cisco cloud migration solutions at Cisco Live, offering deeper visibility, real-time and intelligent insights.
Analiz Makalesi • Aug 11

Some Investors May Be Worried About Integrated Research's (ASX:IRI) Returns On Capital

ASX:IRI 1 Year Share Price vs Fair Value Explore Integrated Research's Fair Values from the Community and select yours...
Analiz Makalesi • Jun 16

When Should You Buy Integrated Research Limited (ASX:IRI)?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it saw a double-digit share price...
Analiz Makalesi • May 09

Integrated Research Limited (ASX:IRI) Shares Fly 29% But Investors Aren't Buying For Growth

Integrated Research Limited ( ASX:IRI ) shareholders would be excited to see that the share price has had a great...
User avatar
Yeni Anlatı • Feb 09

Shifting To High-Value Clients And Launching IR Labs May Improve Stability, But Challenges Remain

Strategic focus on high-value enterprise customers and efficient cost management is expected to enhance net margins and revenue stability.
Analiz Makalesi • Oct 22

Why Integrated Research Limited (ASX:IRI) Could Be Worth Watching

Integrated Research Limited ( ASX:IRI ), might not be a large cap stock, but it saw a decent share price growth of 17...
Analiz Makalesi • Aug 29

Impressive Earnings May Not Tell The Whole Story For Integrated Research (ASX:IRI)

Last week's profit announcement from Integrated Research Limited ( ASX:IRI ) was underwhelming for investors, despite...
Analiz Makalesi • Aug 21

Investors Don't See Light At End Of Integrated Research Limited's (ASX:IRI) Tunnel And Push Stock Down 37%

Integrated Research Limited ( ASX:IRI ) shares have had a horrible month, losing 37% after a relatively good period...
Analiz Makalesi • Jun 28

Integrated Research Limited (ASX:IRI) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Despite an already strong run, Integrated Research Limited ( ASX:IRI ) shares have been powering on, with a gain of 33...
Analiz Makalesi • Jun 11

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

If we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? When we...
Analiz Makalesi • Apr 20

Why Investors Shouldn't Be Surprised By Integrated Research Limited's (ASX:IRI) Low P/S

Integrated Research Limited's ( ASX:IRI ) price-to-sales (or "P/S") ratio of 0.8x might make it look like a buy right...
Analiz Makalesi • Mar 02

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
Analiz Makalesi • Dec 27

Is It Time To Consider Buying Integrated Research Limited (ASX:IRI)?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it saw a decent share price growth...
Analiz Makalesi • Nov 21

A Look At The Intrinsic Value Of Integrated Research Limited (ASX:IRI)

Key Insights Using the Dividend Discount Model, Integrated Research fair value estimate is AU$0.30 Integrated...
Analiz Makalesi • Aug 28

Is Integrated Research Limited (ASX:IRI) Potentially Undervalued?

While Integrated Research Limited ( ASX:IRI ) might not be the most widely known stock at the moment, it received a lot...
Analiz Makalesi • May 12

What Is Integrated Research Limited's (ASX:IRI) Share Price Doing?

Integrated Research Limited ( ASX:IRI ), is not the largest company out there, but it received a lot of attention from...
Analiz Makalesi • Jan 11

Is It Time To Consider Buying Integrated Research Limited (ASX:IRI)?

Integrated Research Limited ( ASX:IRI ), might not be a large cap stock, but it received a lot of attention from a...
Analiz Makalesi • Nov 24

A Look At The Intrinsic Value Of Integrated Research Limited (ASX:IRI)

Today we will run through one way of estimating the intrinsic value of Integrated Research Limited ( ASX:IRI ) by...

Hissedar Getirileri

IRIAU SoftwareAU Pazar
7D-5.0%-7.5%-0.6%
1Y-31.3%-51.4%-0.3%

Getiri vs. Endüstri: IRI geçen yıl % -51.4 oranında getiri sağlayan Australian Software sektörünü aştı.

Getiri vs Piyasa: IRI geçen yıl % -0.3 oranında getiri sağlayan Australian Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is IRI's price volatile compared to industry and market?
IRI volatility
IRI Average Weekly Movement9.4%
Software Industry Average Movement10.6%
Market Average Movement9.7%
10% most volatile stocks in AU Market16.9%
10% least volatile stocks in AU Market4.0%

İstikrarlı Hisse Senedi Fiyatı: IRI son 3 ayda Australian piyasasına kıyasla önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: IRI 'nin haftalık oynaklığı ( 9% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
1988138Ian Lowewww.ir.com

Integrated Research Limited, iş açısından kritik bilgi işlem sistemlerinin performansını izlemeye yönelik yazılımların tasarımı, geliştirilmesi, uygulanması ve satışı ile uğraşmaktadır. Şirket, operasyonel içgörü sağlamak ve HP NonStop, dağıtık sistem sunucuları, Birleşik İletişim, ödeme ortamları ve iş uygulamalarının çalışmasını optimize etmek için entegre bir izleme ve yönetim yazılımı paketi olan Prognosis'i sunmaktadır. Ayrıca, doğal dil yapay zekası olan Iris'i; hizmet olarak sunulan bir platform olan Elevate'i; bakım, SaaS, test çözümleri ve profesyonel hizmetler de sağlamaktadır.

Integrated Research Limited Temel Bilgiler Özeti

Integrated Research'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
IRI temel i̇stati̇sti̇kler
Piyasa değeriAU$51.47m
Kazançlar(TTM)AU$1.21m
Gelir(TTM)AU$57.64m
42.5x
F/K Oranı
0.9x
P/S Oranı

IRI aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
IRI gelir tablosu (TTM)
GelirAU$57.64m
Gelir MaliyetiAU$0
Brüt KârAU$57.64m
Diğer GiderlerAU$56.43m
KazançlarAU$1.21m

Son Raporlanan Kazançlar

Jun 30, 2026

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)0.0067
Brüt Marj100.00%
Net Kâr Marjı2.10%
Borç/Özkaynak Oranı0%

IRI uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

10.5%
Mevcut Temettü Verimi
446%
Ödeme Oranı

IRI güvenilir bir temettü ödüyor mu?

IRI temettü geçmişine ve kıyaslamalara bakın
Yaklaşan bir temettüyü almak için ne zaman IRI satın almanız gerekir?
Integrated Research temettü tari̇hleri̇
Eski Temettü TarihiSep 02 2026
Temettü Ödeme TarihiOct 15 2026
Eski temettüye kadar geçen günler9 days
Temettü ödeme tarihine kadar geçen günler34 days

IRI güvenilir bir temettü ödüyor mu?

IRI temettü geçmişine ve kıyaslamalara bakın

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/09/10 01:42
Gün Sonu Hisse Fiyatı2026/09/10 00:00
Kazançlar2026/06/30
Yıllık Kazançlar2026/06/30

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
  • SEC Form 10-K
  • SEC Form 10-Q
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
  • Analist Araştırma Raporları
  • Blue Matrix
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
  • ICE Piyasa Verileri
  • SEC Form S-1
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
  • SEC Form 4
  • SEC Form 13D
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
  • SEC Form 10-K
  • SEC Form DEF 14A
Önemli Gelişmeler10 yıl
  • Şirket duyuruları
  • SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına Github sayfamızdan ulaşabilirsiniz; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube’da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Integrated Research Limited 4 Bu analistlerden 1, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Chris SavageBell Potter
Katie BelleLodge Partners Pty Ltd.
Todd GuyotMA Moelis Australia Securities Pty Ltd

Her Yerde Daha İyi Yatırım Kararları Alın

İndirmek için tarayın
AppStore’u AçGoogle Play’i Aç
Chrome Web Mağazası
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Veri Kaynaklarını Görüntüle
Piyasalar
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Yatırım Fikirleri
  • Değeri Düşük Şirketler
  • Temettü Santralleri
  • İçeriden Satın Alma
  • Nükleer Enerji
  • Otonom Araçlar
  • Yapay Zeka
  • Kripto ve Blok Zinciri
  • Siber güvenlik
  • Daha fazla fikir
Hisse Toplulukları
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Araçlar ve özellikler
  • Portföy Takibi
  • Hisse Senedi Tarayıcı & Uyarılar
  • Anlatılar ve Adil Değerler
  • Temettü Hesaplayıcı
Haberler ve Keşifler
  • Son Hisse Senedi Haberleri
  • Küresel Pazar İçgörüleri
  • Foxhole
  • Yatırım Fikirleri
  • Topluluk Anlatıları
  • Yenilikler
Simply Wall St
  • Planlar & Fiyatlandırma
  • Reklam
  • Hakkımızda
  • Bize Ulaşın
  • Kariyer
  • Yardım Merkezi
  • Hisse Senedi Yatırımını Öğrenin
  • Ortaklık Programı
  • İşletme ve Kurumsal
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Şartlar ve Koşullar
  • Gizlilik Politikası
  • Yapay Zeka Koşulları
  • Finansal Hizmetler Rehberi